UPLIZNA – NMOSD MAR Display Banners Therapeutic Spotlight – 25898

Differentiating neuromyelitis optica spectrum disorder (NMOSD) and Myelin oligodendrocyte glycoprotein antibody disease (MOG-AD) from multiple sclerosis (MS) is important since MS therapies might result in progression and...

In neuromyelitis optica spectrum disorder (NMOSD), no blood tests to evaluate disease activity, attack severity, or therapy impact have been developed. For a study, the researchers determined the effects of inebilizumab...

Optic neuritis and transverse myelitis are symptoms of neuromyelitis optica spectrum disorder, an autoimmune disease. Attacks can result in severe brain damage, resulting in blindness or paralysis. The discovery of the...

Neuromyelitis optica spectrum disorder (NMOSD) is an autoimmune inflammatory disease of the central nervous system (CNS), also described as CNS autoimmune astrocytopathy, due to the production of pathogenic antibodies against...

Multiple sclerosis (MS) and aquaporin-4 antibody-positive neuromyelitis optica spectrum disorders (NMOSD), which have different pathogenic mechanisms, both negatively affect patients during their lifetime. We aimed to analyze...